BACKGROUND: Pancreatic ductal adenocarcinoma has an extremely poor prognosis. To improve the prognosis, novel molecular markers and targets for earlier diagnosis and adjuvant and/or neoadjuvant treatment need to be identified. One of the key techniques that has been developed to achieve this goal is DNA microarray profiling, which is used to identify the mechanisms of deregulated molecular functions in pancreatic carcinoma cells. OBJECTIVE: As several studies using microarrays have already been published, this review attempts to compare published data and crossvalidate the results. In addition, the applied techniques are discussed. Copyright 2004 Springer-Verlag
BACKGROUND:Pancreatic ductal adenocarcinoma has an extremely poor prognosis. To improve the prognosis, novel molecular markers and targets for earlier diagnosis and adjuvant and/or neoadjuvant treatment need to be identified. One of the key techniques that has been developed to achieve this goal is DNA microarray profiling, which is used to identify the mechanisms of deregulated molecular functions in pancreatic carcinoma cells. OBJECTIVE: As several studies using microarrays have already been published, this review attempts to compare published data and crossvalidate the results. In addition, the applied techniques are discussed. Copyright 2004 Springer-Verlag
Authors: F M Selaru; T Zou; Y Xu; V Shustova; J Yin; Y Mori; F Sato; S Wang; A Olaru; D Shibata; B D Greenwald; M J Krasna; J M Abraham; S J Meltzer Journal: Oncogene Date: 2002-01-17 Impact factor: 9.867
Authors: U Alon; N Barkai; D A Notterman; K Gish; S Ybarra; D Mack; A J Levine Journal: Proc Natl Acad Sci U S A Date: 1999-06-08 Impact factor: 11.205
Authors: M Löhr; B Trautmann; M Göttler; S Peters; I Zauner; A Maier; G Klöppel; S Liebe; E D Kreuser Journal: Pancreas Date: 1996-04 Impact factor: 3.327
Authors: Christine A Iacobuzio-Donahue; Anirban Maitra; Mari Olsen; Anson W Lowe; N Tjarda van Heek; Christophe Rosty; Kim Walter; Norihiro Sato; Antony Parker; Raheela Ashfaq; Elizabeth Jaffee; Byungwoo Ryu; Jessa Jones; James R Eshleman; Charles J Yeo; John L Cameron; Scott E Kern; Ralph H Hruban; Patrick O Brown; Michael Goggins Journal: Am J Pathol Date: 2003-04 Impact factor: 4.307
Authors: Randy S Haun; Charles M Quick; Eric R Siegel; Ilangovan Raju; Samuel G Mackintosh; Alan J Tackett Journal: Cancer Biol Ther Date: 2015-07-15 Impact factor: 4.742
Authors: Henrik Laurell; Michele Bouisson; Philippe Berthelemy; Philippe Rochaix; Sebastien Dejean; Philippe Besse; Christiane Susini; Lucien Pradayrol; Nicole Vaysse; Louis Buscail Journal: World J Gastroenterol Date: 2006-06-07 Impact factor: 5.742
Authors: Christian Pilarsky; Michael Wenzig; Thomas Specht; Hans Detlev Saeger; Robert Grützmann Journal: Neoplasia Date: 2004 Nov-Dec Impact factor: 5.715
Authors: Felix Rückert; Gihan Dawelbait; Christof Winter; Arndt Hartmann; Axel Denz; Ole Ammerpohl; Michael Schroeder; Hans Konrad Schackert; Bence Sipos; Günter Klöppel; Holger Kalthoff; Hans-Detlev Saeger; Christian Pilarsky; Robert Grützmann Journal: PLoS One Date: 2010-08-19 Impact factor: 3.240
Authors: Jeran K Stratford; David J Bentrem; Judy M Anderson; Cheng Fan; Keith A Volmar; J S Marron; Elizabeth D Routh; Laura S Caskey; Jonathan C Samuel; Channing J Der; Leigh B Thorne; Benjamin F Calvo; Hong Jin Kim; Mark S Talamonti; Christine A Iacobuzio-Donahue; Michael A Hollingsworth; Charles M Perou; Jen Jen Yeh Journal: PLoS Med Date: 2010-07-13 Impact factor: 11.069
Authors: M Niedergethmann; F Alves; J K Neff; B Heidrich; N Aramin; L Li; C Pilarsky; R Grützmann; H Allgayer; S Post; N Gretz Journal: Br J Cancer Date: 2007-10-16 Impact factor: 7.640